Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (483)	5/12/1998 4:06:00 PM
From: Joe Dancy	Read Replies (1) \| Respond to of 696

They are selling at about half the value they should be Tom, so BIOI would be a good acquisition. Also, from what management has said companies in this sector have been selling for much more than they are worth from an intrinsic business standpoint, and BIOI has not kept pace with competitor's valuations. That said, the company will do much better for us as long term shareholders if they remain independent. I'm sure there is a reasonable explanation for any meetings, but please pass on any rumors (or e-mail me privately with your comments if you'd rather not post rank speculation here). As a shareholder with a large stake in BIOI I'd like to hear the line, even if it is unfounded. Joe